|
Children Suffering From Vernal Keratoconjunctivitis - Results Of Pivotal Phase III Clinical Trial Wi |
|
www.medicalnewstoday.com/medicalnews.php?newsid=75407&nfid=crss
|
|
Novagali Pharma, an emerging pharmaceutical company specialized in ophthalmology presents positive results of its pivotal phase III clinical trial positive results from the Phase III clinical study of Vekacia® in children suffering from Vernal Keratoconjunctivitis (VKC) at the XIV Afro-Asian Congress of ophthalmology held from June 20 to 25 2007 in Marrakech (Morocco). []
|